chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever, 102.6; earache, dry mouth, body aches, vomiting x 2, bloody nose.
RN gave flu vaccine in error instead of the HPV vaccine to patient during appointment. Patient had already received flu shot for this season 2 days prior to this incident.  No immediate adverse reactions or side effects noted, but patient encouraged to monitor for expected side effects (flu like symptoms) post flu vaccine. Patient acknowledged understanding and was agreeable to also receiving the HPV #1 vaccine.
This spontaneous report as received from a health professional refers to a 12 months old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 30-NOV-2015, the patient was vaccinated with an improperly stored dose of VARIVAX lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient fainted 8 minutes after vaccine. Was checked out and proven to be unharmed by EMS
unable to move my arm in various positions without it hurting; the pain in my arm seems to be increasing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (BNT162B2 OMI XBB.1.5), on 30Sep2023 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 30Sep2023, outcome "not recovered", described as "the pain in my arm seems to be increasing"; MOVEMENT DISORDER (non-serious) with onset 02Oct2023, outcome "unknown", described as "unable to move my arm in various positions without it hurting".  Additional information: The patient reported that "on 02Oct2023 the pain in my arm seems to be increasing and I'm unable to move my arm  in various positions without it hurting. I need my other arm to lift my arm up to put my eyedrops in. Can this be a normal side effect? What should I do?? I would like to talk to someone. Thank you."  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Covid Arm -- began itching and getting hot and red and swollen at injection site after having no symptoms there for a few days
Felt like I had the flu the day after I received my second dose. Headache, body ache, fatigue, chills, nausea. Last about 12 hours.
on 4/15 pt. presents to local ED with c/o SOB. Husband poor hx. but reports that pt. was not taking medications as prescribed. Documentation from MD in ED uncertain if pt. taking her amiodarone, torsemide and elquis.  Noted to have O2 sats on RA of 81%. Pt. was in respiratory distress upon arrival to ER. Pt. was transferred to higher level of care, another Hospital on 4/15/2021 placed on Bipap.
Patient was given a Moderna Covid vaccine instead of the Pfizer Covid vaccine for her 2nd Covid shot in her 2 shot series. Attempted to call patient but so far has not called pharmacy back concerning incident.
The day after receiving the COVID-19 shot, on the same side as I received the shot in (left side) I started to swell under my arm all the way down to my waist.  It's gone down by about 75% at this time, but I'm swill swollen on my left side and it's painful.  I've also been a runner my entire adult life.  My runs have severely been affected, and I run out of breath much easier now, which occurred within 1 month of receiving the vaccine, and I've noticed I run out of energy and have to consume energy drinks and coffee throughout the day in order to make it through the day.
Temperature. Aches and pains throughout muscles and joints in legs and arms. Tylenol for fever.
Moderate to severe vomiting, diarrhea and fever that lasted several hours, followed by 2-3 days of no appetite and moderate to severe fatigue. Followed by 2-3 days of mild fatigue
Three days after receiving first shot the patient experienced an increase in volume of tinnitus.; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: en6206) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 11:15 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history included tinnitus. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within 2 weeks of vaccination. The patient had no known allergies. On an unknown date in Mar2021 at 11:15, three days after receiving his first shot, the patient experienced an increased in volume of his tinnitus. The patient had tinnitus in the right ear for many years but it had always been at a low volume and very manageable. After receiving his first shot, the volume increased to a high level and has remained that way ever since. The volume level since the shot was very distracting and at times very difficult to deal with. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event an increase in volume of the tinnitus was not recovered at the time of this report.
I've been feeling super good since I got vaccinated. I haven't even had to take a Tylenol. I have made my life normal. However, on Thursday, April 1, 2021, around 9:00 p.m., I began to feel tenderness in the area where the vaccine was administered. I have a wide red branch in all that area, it is hot ', I feel a little itchy and it is a little swollen. I feel like little pinpricks in the vaccine area. Nothing had happened to me before.
Patient came to work early to receive Moderna Booster vaccine.  She completed form and Moderna Lot 020B21A expiration date 11/23/21-third dose of 0.25mL drawn from the vial.  EMT administered injection to left deltoid without any complications.  Patient was discussing with us the fact that she still had pain every once and a while in the area of the injection(s).  She also discussed her reaction to the statin injection that occurred a while ago.  Patient stated she was slightly dizzy.  I asked her if that was the only symptom; if she had eaten today.  She stated yes only symptom and she at a little breakfast.  At this time she had been waiting approximately fifteen minutes and was getting her things rea so that she could go to eat something and sit down in her office.  Since still doing shots I instructed her to call me back.  Patient called me back in ten minutes and we discussed on the phone her dizziness not better after having a protein shake.  At this time I sent EMT over to obtain a set of vitals and check her while I completed the last one and packed up the supplies.  When EMT returned to visitation (where vaccines were being administered) He stated he had escorted patient to the clinic to see Dr. due to elivated blood pressure and numbness in arm.   Dr. instructed to recheck blood pressure in ten minutes.  During the ten minutes waiting to do another blood pressure check patient was in the clinic with HSA and other staff.  After the ten minutes Dr., EMT, patient and myself stepped into my office and EMT rechecked blood pressure (184/86).  Dr. stated to be safe patient should be checked at hospital.  This information was relayed to HSA.  Patient was taken by a staff member to medical facility.
This spontaneous report as received from a pharmacy technician refers to a 2 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 19-JAN-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
chest pain; This is a spontaneous report from a contactable consumer. A 72-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL9262) on her left arm, via an unspecified route of administration on 25Jan2021 at a single dose for covid-19 immunization. Medical history included Open heart surgery in 2006. There were no concomitant medications. It was reported that the patient had the COVID shot on the 25Jan2021, she and her husband, and she sat for 20 minutes, everything was fine, she got in the car, and was going down the road, she had chest pains, then it eased up and it stopped then probably another 25 to 30 minutes later is started again. The chest pains started probably a half hour after the shot. They went away, then she had it three times that day, and once today, and once yesterday, so they are ongoing. The outcome of the event was not recovered.
This spontaneous report as received from a pharmacist refers to a 62 years old female patient with diabetes, hypertension and asthma with no relevant medical history. Her relevant past drug history was unknown. The patient was vaccinated with a dose of ZOSTAVAX 0.65 ml subcutaneously in the deltoid area of her left arm (lot number reported as 0242AE, expiration date 01-APR-2013) on 29-AUG-2012. No other co-suspects were reported. Concomitant medications included several unknown medications (unspecified). On 30-AUG-2012, the patient developed a reddened rash in a circular pattern around her left arm at the injection site. No treatment information was reported. The patent had no laboratory testing performed. As of 30-AUG-2012, the patient would not receive another ZOSTAVAX and the outcome of reddened rash in a circular pattern around her left arm at the injection site was unknown. The relatedness for reddened rash in a circular pattern around her left arm at the injection site was not reported for ZOSTAVAX. This is one of two reports received from the same source.
Information has been received from a registered nurse concerning an 18 year old female student with a slight temperature at the time of vaccination (99.9 degrees) (weight 110 pounds, height 60.5 inches) who on the morning of 09-JAN-2009 was vaccinated in the arm with a first dose of GARDASIL.  Concomitant therapy included DORYX, DIFFERIN and FEMCON.  It was reported that the patient after receiving GARDASIL began feeling ill later that evening.  The nurse stated that the patient went to pediatric physician twice and was diagnosed with mononucleosis and mononucleosis caused hepatitis.  The nurse indicated that the patient's mother believes GARDASIL caused or worsened the condition.  Patient not recovered.  Additional information is not expected.
09/27/02 @ 8:00 am-temp. 102 (O). took Tylenol 1000 mg, 09/27/02 @ 12:30 PM, Assessed by RN, Pulse 64/reg, Lungs clear, Temp. 99 (Ax), No S/s of URI; throat, red, but, no exudate or drainage noted. Does not complain if sore throat, but was on "Z Pak" 2 weeks ago for Tonsillitis. Took Tylenol 1000 mg again @ 1:00 pm ,Slept most of day & asymptomatic/febrile by 5:00 pm. Remained symptomatic with exception of soreness @ injection site X 2 days.
10-15 MINUTES POST VACCINATION, PINPOINT HIVES ON TRUNK AND UPPER EXTREMITIES.
The big toe on my left foot started to hurt. It lasted a few days and then went numb on the bottom and tip  and has stayed numb.  Feeling does return on occasion but infrequently and not noticeable usually.
This case was reported by a consumer via call center representative and described the occurrence of pain in a 70-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included ZOSTAVAX (dose received on an unknown date) and SHINGRIX with an associated reaction of headache (1st dose received on 26th June 2018, refer case US2018166441). On 30th August 2018 13:00, the patient received the 2nd dose of SHINGRIX (intramuscular). On an unknown date, less than 2 weeks after receiving SHINGRIX, the patient experienced pain, loss of energy and headache. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the pain, loss of energy and headache were recovered/resolved.  It was unknown if the reporter considered the pain, loss of energy and headache to be related to SHINGRIX. Additional information received as follows: The patient received SHINGRIX on the left deltoid. The patient reported that she was experiencing a headache for a couple of days, feeling achy for a week, and having no energy like she weighed a ton. The contact details of the physician were provided.
PATIENT REPORTED SEVERE ARM PAIN AND LOW GRADE FEVER BEGINNING 3 HOURS AFTER VACCINE ADMINISTRATION THE RESULTED IN EMERGENCY DEPARTMENT VISIT. PATIENT STILL HAVING MINOR PAIN 2 WEEKS POST-INJECTION.
injection site warm to touch; injection site is swollen to the size of a 50 cent piece; injection site itching; injection site red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (injection site warm to touch), INJECTION SITE PRURITUS (injection site itching), INJECTION SITE SWELLING (injection site is swollen to the size of a 50 cent piece) and INJECTION SITE ERYTHEMA (injection site red) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039k20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Dec-2020, the patient experienced INJECTION SITE ERYTHEMA (injection site red). On 07-Jan-2021, the patient experienced INJECTION SITE PRURITUS (injection site itching). On 08-Jan-2021, the patient experienced INJECTION SITE WARMTH (injection site warm to touch) and INJECTION SITE SWELLING (injection site is swollen to the size of a 50 cent piece). At the time of the report, INJECTION SITE WARMTH (injection site warm to touch), INJECTION SITE PRURITUS (injection site itching), INJECTION SITE SWELLING (injection site is swollen to the size of a 50 cent piece) and INJECTION SITE ERYTHEMA (injection site red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Sender's Comment Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Client returned to clinic site after receiving her flu shot earlier. When she noticed swelling to her (R) arm from her fingers to injection site, also complained of tingling and numbness to area also felt hot. Client showed no other signs or symptoms of adverse reaction. Client referred for further evaluation by PCP.
Both of my hands were trembling within 12 hours of taking the vaccine. The next day both hands were still trembling, but then I noticed my legs were trembling. I couldnt keep them still. When Id prop them up or lie down, they were still trembling.; I also felt pain on the back side of my thigh, deep pain, nothing relieved it.; . I had a migraine the entire 3 days.; I had a fast and heavy heartbeat until I woke up the next day.; Injection site was expectedly painful for ~2 days; I had nausea on and off, like motion sickness, for the first 24 hours after inoculation.; I had nausea on and off, like motion sickness, for the first 24 hours after inoculation.; This is a spontaneous report from a non-contactable consumer, the patient. A 29-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0151) via an unspecified route of administration in the left arm on 09Apr2021 at 12:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The medical history included iron deficiency anemia, fibromyalgia, irritable bowel syndrome(IBS), possible endometriosis, allergy to latex and gluten. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included buspirone (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) and vitamin d nos (MANUFACTURER UNKNOWN), all from unknown dates and for unknown indications. On 09Apr2021 at 23:00, within 12 hours of taking the vaccine, the patient experienced trembling on both of her hands, the next day both hands were trembling, but then she noticed her legs were trembling. The patient couldn't keep them still. When the patient prop them up or lie down, they were trembling. The patient also felt pain on the back side of her thigh, it was deep pain and nothing relieved it. This all lasted for 2-3 days and tapered off. The patient  had a migraine the entire three days and had a fast and heavy heartbeat until she woke up the next day. The patient's injection site was expectedly painful for approximately two days. The patient also had nausea on and off, like motion sickness, for the first 24 hours after inoculation. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event trembling on both hands and legs, pain on the back side of the thigh, migraine and injection site pain was recovered on an unknown date in Apr2021, while that of fast and heavy heartbeat, nausea and motion sickness was recovered on 10Apr2021.    No follow-up attempts are possible. No further information is expected.
face was swollen; red rash; "little pimples"; red and swollen eye; swollen eye; FEVER; headache; This spontaneous case was reported by an other health care professional and describes the occurrence of SWELLING FACE (face was swollen), RASH ERYTHEMATOUS (red rash), ACNE ("little pimples"), OCULAR HYPERAEMIA (red and swollen eye) and EYE SWELLING (swollen eye) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (allergic to seafood and pecan nuts)) and Hypertension. Concomitant products included LISINOPRIL for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jan-2021, the patient experienced HEADACHE (headache). On 15-Feb-2021, the patient experienced PYREXIA (FEVER). On 16-Feb-2021, the patient experienced SWELLING FACE (face was swollen). 16-Feb-2021, the patient experienced RASH ERYTHEMATOUS (red rash), ACNE ("little pimples"), OCULAR HYPERAEMIA (red and swollen eye) and EYE SWELLING (swollen eye). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Jan-2021, HEADACHE (headache) had resolved. On 17-Feb-2021, SWELLING FACE (face was swollen), RASH ERYTHEMATOUS (red rash) and PYREXIA (FEVER) had resolved. At the time of the report, ACNE ("little pimples"), OCULAR HYPERAEMIA (red and swollen eye) and EYE SWELLING (swollen eye) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, Body temperature increased: 97 to 99.8°f (High) lasted 6 hours and temperature went from 97 to 99.8°F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medications Lisinopril   This case was linked to MOD21-032007 (Patient Link).
Headache, fever, fatigue, cold sore outbreaks, heavy, irregular,  painful menstral cycles, sore throat, chills, unwell- started next day, got worse  in April 2021, still feeling issues today.
Started with numbness and tingling from left forearm to fingers approximately 5 minutes post injection. Treatment includes ice pack to injection site and rest on left arm for 15 minutes. Instructed to replace ice pack in 20-30 minutes.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. On 01-JUN-2015, the patient was vaccinated with improperly stored GARDASIL (route of administration and dose were not reported) (lot # K023432, expiry date: 18-JUN-2016). No adverse effect was reported. This is one of several reports from the same reporter. Additional information has been requested.
mild case of shingles isolated to her left arm; This case was reported by a physician and described the occurrence of shingles in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, 2 weeks after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The physician called on behalf of spouse of patient. The patient received the first dose of Shingrix in the right deltoid.  In 2020, the patient developed a mild case of shingles isolated to her left arm.  The reporter did not consent to follow-up.
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 27-Jul-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant and treatment medications are provided by the reporter, date of refrigeration is given as 7-May-2021.   This case was linked to MOD-2021-365180 (Patient Link).